Researchers who collected data from men who attended yoga class twice a week during prostate cancer radiation treatment found that they were less fatigued and had better sexual and urinary function.

When first introduced in the 1990s, blood tests for prostate-specific-antigens were hailed as the cheap, non-invasive screening men had needed for years. While the rate of prostate cancer rose sharply, that was expected—a more effective screening test meant more cancers were diagnosed.

IBA Molecular and Mallinckrodt are launching a new radiopharmaceutical company after IBA Molecular acquired Mallinckrodt’s nuclear imaging division in a $690 million sale announced in August 2016.

Melanie Robbins recently won an $8 million medical malpractice lawsuit against a radiology group after a misdiagnosed blood vessel burst in her brain, which in turn left her paralyzed with brain damage.

A group of researchers at Children’s Hospital Los Angeles found that children who were part of a clinical trial to assess the effectiveness of reduced radiotherapy had less successful results when there were deviations from the treatment protocol. 

The dramatic growth in imaging utilization experienced at the beginning of the millennium has mostly leveled off, according to a study published in Health Affairs, primarily due to major cuts to reimbursement and more careful ordering of noninvasive exams.

With more than 25 years of being involved in research to detect and characterize prostate cancers at early stages, John Kurhanewicz, PhD, is using his work to impact patient care.

Establishing concrete protocols for logging unanticipated events in MRI can help imaging practices establish internal performance benchmarks and make data-driven decisions on resource allocation, according to a study published in the Journal of the American College of Radiology.